Skip to main content
CMND
NASDAQ Life Sciences

香港发布Clearmind Medicine的精神活性治疗六项关键专利

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
7
Price
$0.757
Mkt Cap
$1.546M
52W Low
$0.699
52W High
$52.4
Market data snapshot near publication time

summarizeSummary

Clearmind Medicine宣布，香港知识产权部门发布了六项专利。这些专利保护了将Palmitoylethanolamide（PEA）与包括MDMA、LSD、Ketamine、Ibogaine、Psilocybin和DMT在内的各种精神活性化合物相结合的专有组合治疗方法。这一发展显著扩大了该公司的知识产权投资组合，对于处于新兴精神活性治疗领域的早期生物技术公司来说，这一点至关重要。这是在香港于3月16日最近提交专利申请和3月10日发布国际专利申请之后，表明了对IP扩张的持续关注。其IP地位的加强可能会增强其竞争优势和未来商业化前景。

在该公告发布时，CMND的交易价格为$0.76，交易所为NASDAQ，所属行业为Life Sciences，市值约为$154.6万。 52周交易区间为$0.70至$52.40。 这则新闻被评估为积极市场情绪，重要性评分为7/10。 来源：GlobeNewswire。

show_chartPrice Chart

Share this article

Copied!

feed CMND - Latest Insights

CMND
Apr 27, 2026, 7:45 AM EDT
Filing Type: 6-K
Importance Score:
7
Clearmind Medicine Evaluates Lead Candidate CMND-100 for FDA Breakthrough Therapy Designation
Sentiment: Positive
View Wiseek Article
CMND
Apr 27, 2026, 7:41 AM EDT
Source: GlobeNewswire
Importance Score:
7
Clearmind Medicine Eyes FDA Breakthrough Therapy Designation for CMND-100
Sentiment: Positive
View Wiseek Article
CMND
Apr 21, 2026, 6:57 AM EDT
Filing Type: 6-K
Importance Score:
9
Clearmind Medicine Converts $2.68M in Notes into 4.47M Shares, Causing Significant Dilution
Sentiment: Negative
View Wiseek Article
CMND
Apr 20, 2026, 5:18 PM EDT
Filing Type: 6-K
Importance Score:
9
Clearmind Medicine Secures $2.43M in Highly Dilutive Convertible Note Financing
Sentiment: Negative
View Wiseek Article
CMND
Apr 20, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
8
Presidential Executive Order Boosts Psychedelic Drug Development, Favors Clearmind's Pipeline
Sentiment: Positive
View Wiseek Article
CMND
Apr 15, 2026, 9:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Clearmind Medicine's CMND-100 Trial Advances to Next Cohort with Increased Dose After Positive DSMB Review
Sentiment: Positive
View Wiseek Article
CMND
Apr 15, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
CMND-100 Trial Receives DSMB Approval to Advance, Increase Dose
Sentiment: Positive
View Wiseek Article
CMND
Apr 15, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Clearmind Medicine Converts $1.75M in Notes at $0.60/Share, Causing Significant Dilution
Sentiment: Negative
View Wiseek Article
CMND
Apr 14, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
9
Clearmind Medicine Secures $1.575M in Highly Dilutive Convertible Note Financing
Sentiment: Negative
View Wiseek Article
CMND
Apr 14, 2026, 8:23 AM EDT
Filing Type: 6-K
Importance Score:
8
Clearmind Medicine's CMND-100 Meets Primary Endpoint in Phase I/IIa AUD Trial
Sentiment: Positive
View Wiseek Article